InsidersTradesSigma
Total declarations
Company
▲ Purchases (6 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Johnson Shane Aaron, Vice-Président. Director active across 1 companies, notably InMed Pharmaceuticals Inc.. In total, 6 filings have been logged. Total volume traded: €50k. The latest transaction was filed on 6 January 2022 — Acquisition. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations6 total
€9,4678,500 shares@ €1.113738.0% of flow
Common Stock
SEC:0001213900-22-001005·
Ideal exit: 3 Oct 2022 (T+270)
€9,4678,500 shares@ €1.11370.15% mcap19.0% of flow
Common Stock
SEC:0001213900-22-001005:0·
Ideal exit: 3 Oct 2022 (T+270)
€9,4518,093 shares@ €1.167838.0% of flow
Common Stock
SEC:0001213900-21-068212·
Ideal exit: 26 Sept 2022 (T+270)
€9,4518,093 shares@ €1.16780.15% mcap19.0% of flow
Common Stock
SEC:0001213900-21-068212:0·
Ideal exit: 26 Sept 2022 (T+270)
€5,9835,000 shares@ €1.196524.0% of flow
Common Stock
SEC:0001213900-21-059271·
Ideal exit: 12 Aug 2022 (T+270)
€5,9835,000 shares@ €1.19650.092% mcap12.0% of flow
Common Stock
SEC:0001213900-21-059271:0·
Ideal exit: 12 Aug 2022 (T+270)
6 of 6 declarations
About Johnson Shane Aaron
Shane Aaron Johnson is Senior Vice President and General Manager of BayMedica LLC, a subsidiary of InMed Pharmaceuticals Inc. In this role, he oversees the operations and strategy of the company, ensuring growth and innovation.
